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Telemedicine is a rapidly developing application of clinical medicine where medical information is transferred through interactive
audiovisual media for the purpose of consulting remote medical procedures or examinations, reducing the time of consultation
for patients. Teledermatology as an application of telemedicine was developed in 1995: it turns out to be a gradually more ordinary
mean of delivering dermatologic healthcare worldwide and will almost certainly have a greater medical function in the future. In
particular, teledermatology can aid in the prevention and diagnosis of nonmelanoma and melanoma skin cancer; telemedicine
and teledermatology oﬀer the opportunity to make available consultations with experts also by long distance. Overall, patients
seem to accept teledermatology, considering it as an excellent mean to obtain healthcare, particularly in those areas with no
expert dermatologists available. Clinicians have also generally reported aﬃrmative experiences with teledermatology in the skin
cancer field. Further studies focusing on cost eﬀectiveness, patient outcomes, and patient and clinician satisfaction will facilitate to
delineate the potential of teledermatology as a mean of prevention and diagnosis of nonmelanoma and melanoma skin cancer.
1. Introduction
Telemedicine is the practice of healthcare using interac-
tive audio, visual, and data communication; this includes
healthcare delivery, diagnosis, consultation, and treatment,
as well as education and transfer of medical data [1].
Telemedicine may be as simple as two health professionals
discussing a case over the telephone or as complex as using
satellite technology and videoconferencing equipment to
conduct a real-time consultation between medical specialists
in two diﬀerent countries. Telemedicine generally refers to
the use of communications and information technologies
for the delivery of clinical care. This medical practice has
dramatically reduced the time of consultation for patients.
Teledermatology as an application of telemedicine was
developed in 1995 [2]: it turns out to be a gradually
more ordinary mean of delivering dermatologic healthcare
worldwide and will almost certainly have a greater medical
function in the future. During the last years, teledermatology
has gained a lot of interest among scientific community. It
can deeply revolutionize the delivery of dermatology services,
providing equitable services to remote areas and allowing
primary care physicians to refer patients to well-equipped
dermatological services at a distance [3]. Teledermatology
uses telecommunication technologies to transfer informa-
tion to patients via mobile phone and images of skin lesions
to clinicians via the Internet.
Teledermatology can also aid in prevention and diagnosis
of skin cancer. Nowadays, a reduction of morbidity and
mortality of nonmelanoma and melanoma skin cancer is the
most important challenge for dermatology: teledermatology
can be considered a new tool that allows preventing and
diagnosing skin cancers.
2. Prevention
Because solar irradiance is the reason of many dermatologic
eﬀects, a certain number of studies have tried to evaluate
diﬀerent methods to calculate a daily parameter of sun
irradiance. These studies have tried to correlate the daily
parameter with human photoexposure in order to avoid
sunburns and other sun risks [4–7]. Nevertheless, sunscreen
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use is often recommended in order to prevent certain types of
skin cancers and sunburns [8, 9]. From a national Canadian
questionnaire, it has been estimated that only a few part
of population (about 20%) uses sunscreen regularly [10]. A
major cause of nonadherence to sunscreen use is oversight,
but also the misunderstanding about sunscreen uses and
its benefit. In order to avoid the risks of sun exposure,
many educational programs are in progress to inform people
about preventive measures. Many scientific agencies have
calculated, under the leadership of WHO (World Health
Organization), a daily index of sun irradiance to detect the
cut-oﬀ value to avoid sunburn and sun risks. Sun light
composes of a very wide range of electromagnetic waves of
which the human eye is able to perceive light radiations. It
knows that MED (minimal erythemal dose) is defined as
the quantity of UVB able to elicit an erythemal response.
Nevertheless, to calculate skin sensitivity, a new noninvasive
method is a multiband spectrophotometer (skin analyzer)
with two reflectance measures, and other magnitudes which
can be directly correlated to them (e.g., absorbance), a
calculation unit and a data storage unit for calculating the
corresponding MED. This sensitivity varies from individ-
ual to individual and can be determined with diﬀerent
methods [6, 11, 12]. In 2006, Fabbrocini et al. monitored
sun radiation to obtain bioclimatic parameters useful for
evaluating climatic changes in order to get an adequate sun
protection map, set up an experimental photodermatology
service, and promote preventive devices through a system of
customized UV teledosimetry using information technology
such as mobile phones. A total of 450 tourists were selected
in Capri town, and they filled a questionnaire containing
personal information as sex, age, hair colour, eye colour,
phototype, sunscreen used, and sunbathing time. The MED
was measured by the Skin Analyser Q Tan, and, after the
examination, the team of dermatologists compiled a card for
each of them with information about their photosensitivity.
The tourists selected in this project before sun exposure
were informed by SMSs through their mobile phones or
through a light board about the optimal UV dose for their
skin and about an estimate of the residual exposure time
considering the UV irradiance. More exactly, in the study,
the authors correlated the UVI to the phototype of the
subjects studied, thus obtaining an estimate of the maximum
exposure time expressed in minutes to avoid sunburn. A
software instantaneously calculates the exposure time to
avoid sunburn on the basis of the eﬀective erythemal dose
(DE) expressed inMED/h using the following algorithm ST =
60/DE. Therefore, in a typically sunny August day with a
UVI equal to 6 (2.6 MED/h), a phototype I or II at his/her
first sun exposure would develop a sunburn after about 20
minutes, while in a moderately pigmented subject this would
take some hours [13]. Armstrong et al. also used SMSs as a
reminder strategy to improve adherence to sunscreen appli-
cation. A group of seventy people were enrolled. Half of them
received daily SMS reminders through their mobile phones
for 6 weeks, and the other half did not receive reminders.
The SMSs reminder consisted of two components: a “hook”
text detailing daily local weather information and a “prompt”
text reminding users to apply sunscreen. This methodology
showed that a simple daily reminder could maintain adher-
ence to sunscreen application; in fact the participants who
received the SMS reminders were nearly twice as adherent
to a regimen of daily sunscreen application respect with
control participants who did not receive SMS reminders
[14]. Previous studies that had just examined the use of
text messaging in health care have found that text-message
reminders improve outpatient clinic attendance [15–19],
encourage weight loss [20], and provide support to diabetic
patients [21]. The results of these studies confirm that text
messages or SMSs can promote behavioural changes. In fact,
SMSs can be used to promote preventive health behaviours
or help individuals adhere to medication regimens for
several reasons. The mobile phone renders the people
readily available, and the SMS is a simple, low cost, and
immediate method of delivering reminders without using
the computers, but the point more important is that text
messaging may be attractive to younger people, an important
target population for development of positive preventive
health habits. Despite numerous recommendations, people
have yet to understand the problems related to excessive
sun exposure and the importance of using sunscreen. The
results of these studies suggest that text-message reminders
reach a large number of people at low cost. Introduction of a
program that incorporates text-message reminders to a large
population may be an innovative preventive health measure
against the development of skin cancer.
3. Diagnosis
Dermoscopy is a noninvasive, in vivo technique and has the
potential to improve up to 49% the diagnostic accuracy for
melanoma and nonmelanoma skin cancer, if used by experts
[22–24] . In 1998, Provost et al. made the first step in the
creation of an international teledermoscopy network, using
a store-and-forward technology with dermoscopic images
[25]. Teledermoscopy represents a recent development of
teledermatology. Dermoscopic images of pigmented skin
lesions can be transmitted through internet to remote tele-
consultants. The feasibility of teledermoscopy reveals a 91%
consensus between the face-to-face diagnosis and the remote
diagnosis [26]. The Consensus NetMeeting of dermoscopy
(a virtual meeting of experts from all over the world) was
another evident example of the practical applicability of
the use of dermoscopy via the Internet [27]. In 2003, a
pilot study of the dermoscopic-pathologic approach using
telediagnosis for melanocytic skin neoplasms revealed that
the diagnostic accuracy reached 83% versus gold standard
(conventional histopathologic diagnosis by experts) [28].
A 2-step teledermatologic approach may be feasible in
managing individuals with multiple pigmented skin lesions
[29]. Recently, teledermoscopy was evaluated as a filtering
system on 219 pigmented skin lesions. Teleconsultations
were sent from general practitioners to the pigmented skin
lesion clinic of the Department of Dermatology, University
of Seville, in Seville, Spain, and 49% of the patients were
referred to the FTF Clinic. There was agreement among the
teleconsultants for both the diagnosis (k = 0.91) and for the
management options (k = 0.92) [30].
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Teledermoscopy seems to be suitable as a triage system.
In this regard, Tan et al. evaluated if teledermoscopy
could be considered as a triage tool of patients referred
to a skin lesion clinic. Two-hundred patients referred to a
dermatology skin lesion clinic were recruited, and a total of
491 lesions were seen. Digital and dermoscopic photographs
were taken of skin lesions of concern, and the patients
were then seen independently face-to-face by two out of
three dermatologists. The digital images were evaluated
4 weeks later, as a teledermoscopy consultation, by two
of these dermatologists. The diagnosis and management
from both types of consultation were compared. There was
excellent agreement between teledermoscopy and face-to-
face diagnosis with only 12.3% of lesions having disparate
diagnoses of clinical significance. Only 12 of 491 lesions
appeared to have been underreported by teledermoscopy
when compared with face-to-face diagnosis. However, when
histopathology became available, only one malignant lesion
had been missed (a basal cell carcinoma diagnosed as solar
keratosis) by teledermoscopy. Teledermoscopy approximated
100% sensitivity and 90% specificity for detecting melanoma
and nonmelanoma skin cancers. Importantly, 74% of all
lesions were determined to be manageable by the general
practitioner without needing to be seen face-to-face by a
dermatologist [31].
Massone et al. also investigated the feasibility of tele-
consultation using a new generation of cellular phones
in pigmented skin lesions. 18 patients were selected con-
secutively in the Pigmented Skin Lesions Clinic of the
Department of Dermatology, Medical University of Graz,
Graz (Austria). The face-to-face (FTF) diagnoses (16 benign
lesions and 2 melanomas) were made in each case. Clinical
and dermoscopic images were acquired using a Sony Ericsson
K 750i with a built-in two-megapixel camera and a pocket
dermoscopy device with a 25 mm 10x lens (DermLite II
PRO HR (3Gen, LLC—Dana Point, USA)) on which the
cellular phone was applied. Two teleconsultants reviewed
the images on a specific web application where images had
been uploaded in JPEG format. Compared to the face-to-
face diagnoses, the two teleconsultants obtained a score of
correct telediagnoses of 89% and of 91.5% reporting the
clinical and dermoscopic images, respectively [32]. Anyway,
in a NHS R&D Technology Assessment, patients referred to
a 2-week wait clinic were invited to have a series of digital
photographs, with and without dermoscopy, immediately
before their face-to-face consultation. A surprisingly high
proportion (33%) of referrals proved to have a cutaneous
malignancy or a severely dysplastic lesion, with almost 22%
having a malignant melanoma or squamous cell carcinoma,
possibly reflecting the rise in incidence of skin cancers
reported elsewhere. If the highest level of clinician confidence
had been applied, no cancers would have been missed, but
only 20% of patients would have avoided an outpatient
appointment. It was concluded that it is unlikely that this
approach can dramatically reduce the need for conventional
clinical consultations while still maintaining patient safety
[33].
Unfortunately, according to previous observations, tele-
dermoscopy of hypopigmented or nonpigmented lesions
cannot always significantly improve diagnostic accuracy.
Fabbrocini et al. focused on 44 not very common lesions
in the clinical practice, characterized by poor and/or absent
pigmentation, absence of regular network, and a diameter
<5mm. The 44 lesions examined by the two observers
consisted of 39 melanocytic lesions (12 Spitz naevi, 9
melanomas, 8 melanomas in situ, 7 Clark naevi, 2 dermal
naevi, and 1 Spitzoid melanoma) and 5 nonmelanocytic
lesions (2 seborrheic keratosis, 1 dermatofibroma, 1 haeman-
gioma, and 1 Bowen papulosis). All the lesions were histo-
pathologically confirmed after clinical and dermoscopic
diagnoses. They chose these kinds of lesions with high
diagnosis complexity either clinically or dermoscopically
to evaluate the reliability of using teledermoscopy for the
diagnosis of rare and atypical lesions. The pattern analysis
and the 7-point checklist were applied to all 44 skin lesions
for the early detection of melanoma. The interobserver
agreement and the agreement between face-to-face diag-
nosis and telediagnosis were assessed. The agreement was
investigated using Cohen’s K statistics. With respect to the
pattern analysis, it was observed that some features, such as
leaf-like areas, milia-like cysts/comedo-like openings, blue-
white structures, and blotches, are detected with the same
frequency in face-to-face and teledermoscopic observations.
Regarding pigment network, regression structures, and dif-
fuse pigmentation, the results showed that they were more
evident in teledermoscopic observation, whereas vascular
pattern, radial streaks, and dots/globules had lower detection
frequency. With respect to the 7-point checklist, it was
noticed that irregular pigmentation and regression structures
had a higher frequency in teledermoscopic observation; all
other criteria were better detected in face-to-face observa-
tion. A significant diﬀerence in total score derived from
7-point checklist analysis was evident between face-to-face
observation and teledermoscopic observation; lesions with a
score equal or superior to 3 were foundmostly in face-to-face
observation. The agreement, evaluated through Cohen’s K ,
between the 1st and the 2nd observer on clinical diagnosis
was very low (K = 0.362). Moderate agreement (K =
0.435) was detected between the 1st and the 2nd observer
on dermoscopic diagnosis; this suggested that dermoscopy
improved clinical diagnosis. this suggested that dermoscopy
improved clinical diagnosis. These data showed that teledi-
agnosis, compared with face-to-face diagnosis, presented a
lower diagnostic accuracy [34].
4. Conclusion
Teledermatology has gained a lot of interest among scientific
community. It can deeply revolutionize the delivery of
dermatology services, providing equitable services to remote
areas and allowing primary care physicians to refer patients
to well-equipped dermatological services at a distance.
Images can be transmitted via a virtual private network to the
teledermoscopists, and those ones can be made mobile as the
technology is portable, overcoming geographical barriers,
and delivering service to remote areas [35–37].
In particular, teledermatology can aid in the prevention
and diagnosis of nonmelanoma and melanoma skin cancer.
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Patients seem to accept teledermatology, considering it as
an excellent mean to obtain healthcare, particularly in those
areas with no expert dermatologists available. The use of
innovative mobile technology can improve prevention cam-
paign, reaching young people too [38]. Clinicians have also
generally reported aﬃrmative experiences with telederma-
tology, excluding for the diagnosis of “pink” lesion. Further
studies focusing on cost eﬀectiveness, intrinsic limits, and
patient and clinician satisfaction will facilitate to delineate
the potential of teledermatology as a mean of dermatologic
healthcare delivery.
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